4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000060
EVP, Finance & CFO sold 8,870 shares at $32.81 ($290,989)
- EVP, Finance & CFO acquired 23,887 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HOUGEN ELIZABETH L · EVP, Finance & CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 1 in the form | +23,887 | 116,755 | D | ||
| 2025-01-16 | Sale : show line 2 in the form | −8,870 | $32.81 | $290,989 | 107,885 | D |
| Open-market sales · 8,870 sh · avg $32.81 · $290,989 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +31,000 | 86,635 | D |
| 2025-01-15 | Grant or award : show line 4 in the form Restricted Stock Unit | +46,500 | 108,556 | D |
| 2025-01-15 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −23,887 | 84,669 | D |
Loading xslF345X05/edgardoc.xml…